294 related articles for article (PubMed ID: 30333359)
1. A randomized, open-label, comparative study of oral tranexamic acid and tranexamic acid microinjections in patients with melasma.
Khurana VK; Misri RR; Agarwal S; Thole AV; Kumar S; Anand T
Indian J Dermatol Venereol Leprol; 2019; 85(1):39-43. PubMed ID: 30333359
[TBL] [Abstract][Full Text] [Related]
2. Oral tranexamic acid for the treatment of melasma.
Karn D; Kc S; Amatya A; Razouria EA; Timalsina M
Kathmandu Univ Med J (KUMJ); 2012; 10(40):40-3. PubMed ID: 23575051
[TBL] [Abstract][Full Text] [Related]
3. A comparative evaluation of the efficacy of intralesional tranexamic acid versus platelet rich plasma in the treatment of melasma.
Patil NK; Bubna AK
Dermatol Ther; 2022 Jul; 35(7):e15534. PubMed ID: 35460158
[TBL] [Abstract][Full Text] [Related]
4. Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial.
Lee JH; Park JG; Lim SH; Kim JY; Ahn KY; Kim MY; Park YM
Dermatol Surg; 2006 May; 32(5):626-31. PubMed ID: 16706756
[TBL] [Abstract][Full Text] [Related]
5. Study of oral tranexamic acid, topical tranexamic acid, and modified Kligman's regimen in treatment of melasma.
Sahu PJ; Singh AL; Kulkarni S; Madke B; Saoji V; Jawade S
J Cosmet Dermatol; 2020 Jun; 19(6):1456-1462. PubMed ID: 32346962
[TBL] [Abstract][Full Text] [Related]
6. A Randomised, Open-label, Comparative Study of Tranexamic Acid Microinjections and Tranexamic Acid with Microneedling in Patients with Melasma.
Budamakuntla L; Loganathan E; Suresh DH; Shanmugam S; Suryanarayan S; Dongare A; Venkataramiah LD; Prabhu N
J Cutan Aesthet Surg; 2013 Jul; 6(3):139-43. PubMed ID: 24163529
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy and safety of oral tranexamic acid and that of tranexamic acid local infiltration with microinjections in patients with melasma: a comparative study.
Sharma R; Mahajan VK; Mehta KS; Chauhan PS; Rawat R; Shiny TN
Clin Exp Dermatol; 2017 Oct; 42(7):728-734. PubMed ID: 28649780
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy and safety of oral tranexamic acid 250 mg once a day versus 500 mg twice a day: a comparative study.
Chowdhary B; Mahajan VK; Mehta KS; Chauhan PS; Sharma V; Sharma A; Vashist S; Kumar P
Arch Dermatol Res; 2021 Mar; 313(2):109-117. PubMed ID: 32356007
[TBL] [Abstract][Full Text] [Related]
9. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
[TBL] [Abstract][Full Text] [Related]
10. Oral tranexamic acid lightens refractory melasma.
Tan AWM; Sen P; Chua SH; Goh BK
Australas J Dermatol; 2017 Aug; 58(3):e105-e108. PubMed ID: 27173008
[TBL] [Abstract][Full Text] [Related]
11. Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma.
Del Rosario E; Florez-Pollack S; Zapata L; Hernandez K; Tovar-Garza A; Rodrigues M; Hynan LS; Pandya AG
J Am Acad Dermatol; 2018 Feb; 78(2):363-369. PubMed ID: 28987494
[TBL] [Abstract][Full Text] [Related]
12. Clinical Efficacy of Topical Tranexamic Acid With Microneedling in Melasma.
Kaur A; Bhalla M; Pal Thami G; Sandhu J
Dermatol Surg; 2020 Nov; 46(11):e96-e101. PubMed ID: 32769524
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of oral vs different dilutions of intradermal tranexamic acid microinjections in melasma-A randomized clinical trial.
El Hadidi H; Mosaad R; Ragab N
Dermatol Ther; 2021 May; 34(3):e14924. PubMed ID: 33651442
[TBL] [Abstract][Full Text] [Related]
14. Combination of Oral Tranexamic Acid with Topical 3% Tranexamic Acid versus Oral Tranexamic Acid with Topical 20% Azelaic Acid in the Treatment of Melasma.
Malik F; Hanif MM; Mustafa G
J Coll Physicians Surg Pak; 2019 Jun; 29(6):502-504. PubMed ID: 31133144
[TBL] [Abstract][Full Text] [Related]
15. Comparison of efficacy and safety of tranexamic acid mesotherapy versus oral tranexamic acid in patients with melasma undergoing Q-switched fractional 1064-nm Nd:YAG laser: A blinded RCT and follow-up.
Behrangi E; Shemshadi M; Ghassemi M; Goodarzi A; Dilmaghani S
J Cosmet Dermatol; 2022 Jan; 21(1):279-289. PubMed ID: 34724323
[TBL] [Abstract][Full Text] [Related]
16. The optimal dose of oral tranexamic acid in melasma: A network meta-analysis.
Wang WJ; Wu TY; Tu YK; Kuo KL; Tsai CY; Chie WC
Indian J Dermatol Venereol Leprol; 2023; 89(2):189-194. PubMed ID: 36332095
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of topical versus intradermal injection of Tranexamic Acid In Egyptian melasma Patients: A randomised clinical trial.
Badran AY; Ali AU; Gomaa AS
Australas J Dermatol; 2021 Aug; 62(3):e373-e379. PubMed ID: 33782959
[TBL] [Abstract][Full Text] [Related]
18. Tranexamic acid microinjections versus tranexamic acid mesoneedling in the treatment of facial melasma: A randomized assessor-blind split-face controlled trial.
Poostiyan N; Alizadeh M; Shahmoradi Z; Fatemi Naeini F
J Cosmet Dermatol; 2023 Apr; 22(4):1238-1244. PubMed ID: 36606390
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the effect of different doses of oral tranexamic acid on melasma: a multicentre prospective study.
Zhu CY; Li Y; Sun QN; Takada A; Kawada A
Eur J Dermatol; 2019 Feb; 29(1):55-58. PubMed ID: 30734717
[TBL] [Abstract][Full Text] [Related]
20. A randomized, open-label study to compare two different dosing regimens of oral tranexamic acid in treatment of moderate to severe facial melasma.
Bhattacharjee R; Hanumanthu V; Thakur V; Bishnoi A; Vinay K; Kumar A; Parsad D; Kumaran MS
Arch Dermatol Res; 2023 Aug; 315(6):1831-1836. PubMed ID: 36757440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
